Cancer Research UK partners with VC firm in $25m deal
03-07-2019
gevende / iStockphoto.com
Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million ($18.4 million) investment from charity Cancer Research UK.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Cancer Research UK, biotherapeutics, cancer, precision medicine, Francis Crick Institute, research and development, UCL, King’s College, Queen Mary